Clinical Trials Logo

Filter by:
NCT ID: NCT01728649 Withdrawn - Ischemic Stroke Clinical Trials

Reperfusion With Cooling in Cerebral Acute Ischemia II

ReCCLAIM II
Start date: February 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether reducing a patients body temperature (mild hypothermia of 33 degrees Centigrade) will significantly reduce the risk of brain injury (notably reperfusion injury and hemorrhagic conversion) in patients that have suffered a significant interruption of blood flow to an area of brain (occlusion of large proximal cerebral artery) and have undergone successful removal of that interruption (revascularization).This will be achieved by comparing patients that have undergone hypothermia to those that have not.

NCT ID: NCT01726660 Withdrawn - Stroke Clinical Trials

The General Use of Robots in Stroke Recovery

Start date: February 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if tailoring multiple sessions of upper extremity robotic therapy to focus on a particular aspect of movement (e.g smoothness vs. aiming; active range of motion vs. functional practice)can optimize therapeutic results and lead to greater functional returns in arm mobility after stroke.

NCT ID: NCT01723176 Withdrawn - Clinical trials for Cardiopulmonary Failure

Evaluation of Ultrasound of the Heart in Patients With Low Blood Pressure

Start date: December 2012
Phase: N/A
Study type: Observational

Hypothesis: Goal-directed echocardiography by trained critical care physicians is equivalent to that of echocardiography technicians/cardiologists for the purpose of determining etiology (reason) of cardiopulmonary failure.

NCT ID: NCT01722227 Withdrawn - Type 1 Diabetes Clinical Trials

Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes

Start date: November 2012
Phase: Phase 3
Study type: Interventional

This is the first prospective randomized double-blind placebo-controlled study to investigate the effect of a GLP-1 analog, specifically liraglutide, on blood glucose levels and variability in subjects with type 1 diabetes treated with insulin. Liraglutide is the preferred GLP-1 analog for this study because the pharmacokinetics and pharmacodynamics of the drug are consistent with a sustained duration of action. The current gold standard for management of type 1 diabetes is based on insulin replacement with novel analogs with specified pharmacodynamic profiles or with unique insulin delivery systems (insulin pump therapy). No other adjuvant therapy has demonstrated sustained benefit in this population. This study will also investigate the effect of liraglutide on suppression of glucagon secretion during meal challenges. This is of particular importance since, in the absence of insulin secretion from the β-cell, there is no paracrine inhibition of glucagon secretion by the α-cell. Dysregulation of glucagon secretion may impact the glycemic control and overall pathogenesis in those with type 1 diabetes. The use of CGM technology in this study will allow us to determine the rapidity, consistency, and sustainability of any response to liraglutide.

NCT ID: NCT01721616 Withdrawn - Endometritis Clinical Trials

Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis

Start date: November 2012
Phase: Phase 4
Study type: Interventional

Despite the generalized use of preoperative antibiotic prophylaxis, endometritis remains as the most frequent post-cesarean delivery complication. This increased morbidity translates into extended post-partum antibiotic use and prolongation of hospital stay with the subsequent increase in health care expenses. The current regimen recommended by the American College of Obstetricians and Gynecologists for cesarean delivery prophylaxis (1st generation cephalosporins) does not cover for Ureaplasma Urealyticum, a microorganism that has been associated with an increased risk of endometritis in post-cesarean section patients. Azithromycin, an antibiotic that has both aerobic and some anaerobic coverage, uniquely covers Ureaplasma and would be an excellent second antibiotic for cesarean section chemoprophylaxis. Our hypothesis is that the addition of azithromycin to standard chemoprophylaxis with cefazolin can effect a 25% reduction of post-cesarean section endometritis.

NCT ID: NCT01719471 Withdrawn - Smoking Clinical Trials

fMRI of Stress in Smoking Behavior

Start date: February 2008
Phase: N/A
Study type: Observational

To examine the influence of current daily tobacco smoking on brain activation during stress, tobacco cue, and neutral relaxing conditions

NCT ID: NCT01719458 Withdrawn - Obesity Clinical Trials

Norepinephrine Transporter Imaging in Addiction Disorders

Start date: July 2007
Phase:
Study type: Observational

In this study we propose to study 24 unmedicated abstinent alcohol dependent patients, 24 obese individuals and 24 individually matched healthy control subjects and determine Norepinephrine Transporter (NET) expression in vivo using (S,S)-[11C]MRB and PET.

NCT ID: NCT01719419 Withdrawn - Overweight Clinical Trials

The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects

Start date: March 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if the drug orlistat (Alli, Xenical) decreases the taste for fat in humans.

NCT ID: NCT01718704 Withdrawn - Clinical trials for Erectile Dysfunction Following Radical Prostatectomy

Viberect Penile Vibratory Stimulation to Enhance Recovery of Erectile Function and Urinary Continence Post-Prostatectomy

Start date: April 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate whether using penile vibratory stimulation with the Viberect handheld device can help the recovery of erections and urinary control after radical prostatectomy.

NCT ID: NCT01717846 Withdrawn - Clinical trials for Rheumatoid Arthritis

Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis

RA
Start date: December 2012
Phase: Phase 4
Study type: Interventional

This proposal will test the hypothesis that Orencia affects apoptosis and apoptosis related genes/biomarkers in vivo in rheumatoid arthritis (RA) patients.